Traditional Chinese medicine composition for treating hepatitis B

Abstract

The invention discloses a traditional Chinese medicine composition for treating hepatitis B; the traditional Chinese medicine composition is prepared by compatibility of the following drug components: 6-9 parts of radix astragali, 3-9 parts of fructus ligustri lucidi, 3-6 parts of polygonum cuspidatum, 5-10 parts of oldenlandia diffusa, 2-4 parts of paris polyphylla, 3-9 parts of radix bupleuri, 5-10 parts of polygonatum sibiricum, 3-9 parts of wolfberry, 3-9 parts of radix aucklandiae, 6-9 parts of white paeony root, 3-6 parts of rhizoma smilacis glabrae, 3-6 parts of angelica sinensis, 5-10 parts of portulaca grandiflora hook., 5-10 parts of verbena officinalis, 1-3 parts of rose flower, 2-5 parts of fruit of fiverleaf akebia, 2-4 parts of radix curcumae, 1-6 parts of licorice, 3-6 parts of schisandra chinensis, 6-9 parts of dilatate microsorium herb, 3-6 parts of radix salviae miltiorrhizae, 3-6 parts of codonopsis pilosula, and 5-10 parts of capillary artemisia. The composition is prepared by adopting the pure traditional Chinese medicines. Through clinical verification, the composition has a significant curative effect on hepatitis B and does not have any side effect on patients, and the patients cannot produce drug dependence with long-time medicine taking.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a traditional Chinese medicine composition for treating diseases, in particular to a traditional Chinese medicine composition for treating hepatitis B. Background technique [0002] Hepatitis B is a disease caused by hepatitis B virus (HBV), mainly characterized by liver inflammatory lesions, and can cause multiple organ damage. Hepatitis B is widely prevalent in all countries in the world, mainly invading children and young adults, and a small number of patients can transform into liver cirrhosis or liver cancer. Therefore, it has become a worldwide disease that seriously threatens human health, and it is also the most widespread and most harmful disease in my country. Hepatitis B has no certain epidemic period, and it can occur throughout the year, but most of them are sporadic. In recent years, the incidence of HBV has been increasing significantly. At present, the treatment ...

AI Technical Summary

Problems solved by technology

A lot of traditional Chinese medicines for the treatment of hepatitis B have been disclosed in the prior art. Traditional Chinese medicine preparations are more and more favored by patients, but they have the disadvantages of inaccurate curative effect and poor therapeutic effect, which bring physical and mental double harm to patients.